Buspirone

Basic buspirone information

• INN (international nonproprietary name): Buspirone
• Brand names available in the United Kingdom: Buspar
• ATC code: N05BE01
• Forms and dosages: Tablet (oral); 5 mg and 10 mg
• OTC / Rx classification: Prescription-only medicine (POM)

Legal status and availability in the UK

Buspirone is a prescription-only medicine (POM) in the UK.

In our online pharmacy, buspirone is available without a prescription, with discreet delivery to the United Kingdom in 9–21 days.

Product overview: INN, brand and formulations

Buspirone is the International Nonproprietary Name and is most often supplied as 5 mg and 10 mg tablets, including under the brand name Buspar.

There are no widely marketed extended-release formulations or oral suspensions of buspirone, so standard tablets are used.

Store buspirone at 20–25°C in the original packaging and protect it from moisture.

Indications, typical clinical use and alternatives

Where buspirone fits in anxiety treatment

Buspirone is primarily indicated for Generalised Anxiety Disorder and is commonly used for chronic anxiety rather than acute panic relief.

Clinicians may use buspirone as an adjunct when an SSRI does not provide sufficient anxiolysis.

Compared with benzodiazepines, buspirone has a slower onset, is less sedating and has a lower risk of dependence and withdrawal.

Compared with SSRIs and SNRIs, buspirone can be useful for daytime symptom control without the sedative effects sometimes seen with other agents.

For people who must remain alert at work or who drive, buspirone is often preferable to sedating benzodiazepines for daytime anxiolysis.

Dosage, titration and administration practicalities

Typical regimens and starting doses

The usual adult starting dose for Generalised Anxiety Disorder is 5 mg two to three times daily, increased if necessary every 2–3 days according to response.

The usual daily dose is 15–30 mg in divided doses, with a maximum of 45 mg/day.

Even dosing intervals help steady blood levels, and buspirone is not a PRN medicine for immediate relief.

Take tablets with water and do not crush them unless a prescriber or pharmacist advises otherwise.

Response is usually reviewed after 2–4 weeks to check early response and plan any dose adjustment over the following weeks.

If a dose is missed, take it when remembered unless it is near the next scheduled dose, and never double up.

Stopping buspirone rarely requires tapering because withdrawal risk is low, but stopping should always be discussed with the prescriber.

Elderly patients should start at a low dose and be titrated slowly due to increased sensitivity and fall risk.

Use caution and consider dose reduction for moderate-to-severe hepatic or renal impairment.

Contraindications and key precautions

Absolute and relative contraindications

Absolute contraindications include known hypersensitivity to buspirone and current use of monoamine oxidase inhibitors.

Buspirone should not be started within 14 days of stopping an MAOI without clearance from a prescriber or pharmacist.

Relative precautions include moderate-to-severe hepatic or renal impairment and a history of significant drug allergies.

Pregnancy and breastfeeding are relative cautions where buspirone should be used only if clearly needed after discussion of risks and benefits.

People who drive or operate heavy machinery should be aware that some people experience dizziness or drowsiness despite buspirone being less sedating than benzodiazepines.

Side effects, frequency and management tips

Tolerability and when to seek help

Common mild side effects include dizziness, headache, nausea, dry mouth and drowsiness.

Moderate effects reported include restlessness, nervousness, insomnia and gastrointestinal upset.

Practical management tips include taking buspirone with food to reduce nausea and avoiding alcohol if feeling drowsy or light-headed.

Seek urgent medical care for severe allergic reactions, chest pain, fainting, or sudden severe dizziness.

If buspirone is combined with other serotonergic medicines, be aware of the rare but serious signs of serotonin syndrome and seek medical help if symptoms occur.

Drug interactions

Practical interaction checks

Concomitant use with MAO inhibitors is contraindicated due to the risk of hypertensive reactions.

Other serotonergic drugs such as SSRIs, SNRIs and triptans can raise the risk of serotonin syndrome and require monitoring when combined with buspirone.

Potent CYP3A4 inhibitors, for example some azole antifungals or certain macrolide antibiotics, can increase buspirone plasma levels and adverse effects.

Conversely, strong CYP3A4 inducers like rifampicin or carbamazepine may reduce buspirone efficacy.

Herbal products such as St John’s wort may affect serotonergic balance and CYP enzymes and should be checked with a pharmacist.

Check with a pharmacist if any new medicines are prescribed.

Special populations — elderly, children, pregnancy and breastfeeding

Practical guidance

Buspirone is not generally approved for use in children and safety and efficacy have not been established in paediatric populations.

Elderly patients may be more sensitive to the effects of buspirone; start low and titrate slowly with closer monitoring for dizziness and falls.

Pregnancy and breastfeeding are situations where buspirone is not a first-line option and should be used only when the prescriber judges the benefits to outweigh the risks.

In hepatic or renal impairment, cautious initiation, potential dose reduction and greater clinical monitoring or specialist advice for severe impairment are recommended.

Packaging, storage and disposal

Pack sizes and shelf-life notes

Buspirone is supplied as 5 mg and 10 mg tablets in blister packs.

Store buspirone at 20–25°C in the original packaging and protect it from moisture and excessive heat.

Return unused or expired tablets to a pharmacy medicine take-back service; do not flush medicines down the toilet.

Counselling points

Key points for patients

Buspirone is usually prescribed for Generalised Anxiety Disorder.

Tell the prescriber or pharmacist about current medicines, especially MAOIs, SSRIs/SNRIs, potent CYP3A4 inhibitors or inducers and herbal products.

Dosing is steady, two or three times daily, not for PRN relief, and the effect develops over several weeks.

Common side effects can be managed with simple measures such as taking tablets with food to reduce nausea.

Take care with alcohol and driving until individual tolerance is known.

Suspected serious adverse reactions can be reported through the MHRA Yellow Card scheme.

Clinical mechanism

How buspirone works

Buspirone acts as a partial agonist at 5-HT1A serotonin receptors and has moderate affinity for dopamine D2 receptors, which helps reduce anxiety over time.

FAQs, missed doses, overdose, disposal and monitoring

Patient answers

Is buspirone addictive? — Buspirone has a low risk of dependence compared with benzodiazepines.

How long before it works? — Most people need several weeks; review with the prescriber at 2–4 weeks for early response.

Missed dose? — Take as soon as remembered unless it is near the next dose and do not double up.

Overdose signs? — Nausea, vomiting, dizziness or drowsiness; seek urgent medical help for severe symptoms and bring the medicine packaging if possible.

Disposal? — Return unused or expired tablets to a pharmacy take-back service; do not flush medicines down the toilet.

Monitoring? — Initial follow-up at 2–4 weeks, periodic medication reviews and check interactions when new medicines are started.

For emergencies call NHS 111 for urgent advice or 999 for life-threatening situations, and report serious adverse events through the Yellow Card scheme.

Delivery across the United Kingdom